Liver Grafts Feasible From Hep C-Positive Donors After Circulatory Death
By Lori Solomon HealthDay Reporter
WEDNESDAY, Sept. 4, 2024 -- Liver grafts from hepatitis C virus-positive (HCV+) donation after circulatory death (DCD) donors have one-year patient and graft survival comparable with that of donation after brain death (DBD) liver grafts from donors with or without HCV infection, according to a study published online Aug. 22 in Transplantation.
Sai Rithin Punjala, M.D., from The Ohio State University in Columbus, and colleagues evaluated organ utilization and outcomes of liver grafts from DCD donors with HCV infection. The analysis included national registry and local center data of all deceased donor liver transplants performed between November 2016 and December 2021.
The researchers found that out of 146 U.S. liver transplant centers, liver transplants were not performed from DCD donors, HCV-positive donors, and a combination of DCD and HCV-positive donors by 28.7, 27, and 70 to 72 percent of centers, respectively. An increasing center acceptance ratio was associated with increased utilization of liver grafts from DCD HCV-negative and DCD HCV antibody-positive nucleic acid test negative donors. Overall, one-year graft survival of HCV-negative DCD liver grafts was lower compared with other groups (89 versus 92 percent HCV-positive DCD versus 93 percent HCV-positive DBD versus 92 percent HCV-negative DBD).
"These results encourage the widespread use of liver grafts from DCD and HCV-positive donors and standardization of practice in DCD donation to expand the donor pool without compromising short-term outcomes," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2024
Read this next
Perioperative Mortality Low for Living Kidney Donors
THURSDAY, Aug. 29, 2024 -- Perioperative mortality has decreased after living kidney donation, with 0.9 deaths per 10,000 during 2013 to 2022, according to a research letter...
Uterus Transplant Feasible, Linked to High Rate of Live Birth
MONDAY, Aug. 19, 2024 -- Uterus transplant is feasible and is associated with high rates of live birth after successful graft survival, according to a study published online Aug...
Acceptable Liver Transplant Outcomes Seen After ICI Therapy for Liver Cancer
FRIDAY, Aug. 16, 2024 -- For patients with hepatocellular carcinoma (HCC), immune checkpoint inhibitor (ICI) use prior to liver transplant (LT) does not worsen outcomes, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.